These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3946 related items for PubMed ID: 7542946

  • 1. [Immunotherapy of malignant diseases].
    Dorval T, Michon J, Tartour E, Fridman WH.
    Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
    [Abstract] [Full Text] [Related]

  • 2. Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy.
    Reisfeld RA, Gillies SD.
    J Clin Lab Anal; 1996; 10(3):160-6. PubMed ID: 8731505
    [No Abstract] [Full Text] [Related]

  • 3. [Biotherapy of cancer].
    Subirá ML, Brugarolas A.
    Rev Clin Esp; 1992 Jun; 191(2):102-8. PubMed ID: 1380172
    [No Abstract] [Full Text] [Related]

  • 4. Molecular approaches to cancer immunotherapy.
    Forni G, Cavallo F, Consalvo M, Allione A, Dellabona P, Casorati G, Giovarelli M.
    Cytokines Mol Ther; 1995 Dec; 1(4):225-48. PubMed ID: 9384678
    [Abstract] [Full Text] [Related]

  • 5. Biologic therapy of melanoma with cytokines and lymphocytes.
    Bear HD, Hamad GG, Kostuchenko PJ.
    Semin Surg Oncol; 1996 Dec; 12(6):436-45. PubMed ID: 8914208
    [Abstract] [Full Text] [Related]

  • 6. [Interleukin-2 and cancer immunotherapy].
    Ogarkov VI, Dobkin AI, Ryzhova EV, Okulov VB, Kiselev OI.
    Vopr Onkol; 1989 Dec; 35(2):141-50. PubMed ID: 2648678
    [No Abstract] [Full Text] [Related]

  • 7. [Immunotherapy of metastatic renal cell cancer].
    Manseck A, Wirth M.
    Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
    [Abstract] [Full Text] [Related]

  • 8. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C, Fleckenstein K, Lohr J, Li CY, Wenz F, Lohr F.
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [Abstract] [Full Text] [Related]

  • 9. Cancer immunotherapy.
    Richman SP, Gutterman JU, Hersh EM.
    Can Med Assoc J; 1979 Feb 03; 120(3):322-4, 329. PubMed ID: 371776
    [Abstract] [Full Text] [Related]

  • 10. [Anemia and immunotherapy].
    Dorval T.
    Bull Cancer; 2003 Apr 03; 90 Spec No():S158-60. PubMed ID: 12856428
    [Abstract] [Full Text] [Related]

  • 11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Apr 03; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 12. [Cancer immunotherapy: new approaches].
    Blay JY, Thomachot MC, Alberti L, Bachelot T, Voorzanger-Rousselot N, Puisieux I, Odin L, Ménétrier-Caux C.
    Bull Cancer; 2000 Jan 03; 87(1):97-106. PubMed ID: 10673638
    [No Abstract] [Full Text] [Related]

  • 13. New therapies for malignant melanoma.
    Hancock B.
    Practitioner; 1989 Oct 22; 233(1477):1385-6, 1388. PubMed ID: 2482487
    [Abstract] [Full Text] [Related]

  • 14. [Immunotherapy of parenchymal tumors. Recent progress and theoretical considerations].
    Marincola F, Smolik L, Annoni F, Holter WD.
    Minerva Chir; 1988 Jul 31; 43(13-14):1111-31. PubMed ID: 3054627
    [No Abstract] [Full Text] [Related]

  • 15. Cancer immunotherapy.
    Schuster M, Nechansky A, Kircheis R.
    Biotechnol J; 2006 Feb 31; 1(2):138-47. PubMed ID: 16892244
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy with lymphokine combinations.
    Mulé JJ, Rosenberg SA.
    Important Adv Oncol; 1989 Feb 31; ():99-126. PubMed ID: 2468602
    [No Abstract] [Full Text] [Related]

  • 17. Biologicals and biological response modifiers: fourth modality of cancer treatment.
    Oldham RK.
    Cancer Treat Rep; 1984 Jan 31; 68(1):221-32. PubMed ID: 6198081
    [Abstract] [Full Text] [Related]

  • 18. [Carcinogenesis and immunobiology of tumors. Scientific and clinical aspects].
    Granov AM, Molchanov OE.
    Vopr Onkol; 2008 Jan 31; 54(4):401-9. PubMed ID: 18942393
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy.
    Wojtowicz-Praga S.
    J Immunother; 1997 May 31; 20(3):165-77. PubMed ID: 9181454
    [Abstract] [Full Text] [Related]

  • 20. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T.
    Kekkaku; 1980 Aug 31; 55(8):359-63. PubMed ID: 6999203
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 198.